Christina Rees – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Christina Rees on 2015-11-23.

To ask the Secretary of State for Health, what steps he has taken to consult clinicians on his policy on access to off-patent drugs.

George Freeman

Our policy on generic prescribing has been in place for a number of years. The policy helps ensure that patients can access the medicine that best meets their needs and it has been a key driver in the National Health Service making maximum use of off-patent drugs which are also known as generics. We have the best prescribing rate for these drugs in Europe.

To support clinicians who may want to prescribe a product off-label for a patient to and improve the flow of research evidence into clinical practice, the Department hosted a Roundtable Event in February 2015. Attendees included the National Institute for Health and Care Excellence, Medicines and Healthcare products Regulatory Agency, Breast Cancer Now and other charities and discussions helped determine those non-legislative measures that could be undertaken. The Government is committed to this work and is holding a further roundtable event with charities.